Your session is about to expire
← Back to Search
ERG, all participants for Post-Traumatic Stress Disorder (BRIGHT Trial)
BRIGHT Trial Summary
This trial aims to investigate if the electroretinogram (ERG) can be used as a biomarker to understand how selective serotonin reuptake inhibitors (SSRIs) like sertral
BRIGHT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BRIGHT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research involve individuals who have reached the age of 18 or older?
"To be considered for inclusion in this research, applicants must fall between 21 and 75 years of age."
What is the upper limit for patient enrollment in this medical study?
"Affirmative. Information from clinicaltrials.gov indicates that this ongoing medical study is actively inviting participants. Originally posted on February 12, 2024, and most recently revised on April 10, 2024, the trial aims to enroll about 50 individuals at a single designated site."
Which individuals are considered more suitable candidates for participation in this medical study?
"Individuals aged between 21 and 75 years old diagnosed with post-traumatic stress disorder are eligible to participate in this study, which aims to enroll a maximum of 50 participants."
Is this medical research study currently open for enrollment?
"Yes, the information available on clinicaltrials.gov indicates that this investigation is actively seeking volunteers. Initially uploaded on February 12th, 2024, with the latest update done on April 10th, 2024. The trial aims to enroll fifty participants from a single location."
Share this study with friends
Copy Link
Messenger